An analysis of polygenic risk scores for non-alcoholic fatty liver disease

被引：5
|
作者：
Jun, Dae Won [1 ]
机构：
[1] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2021年 / 27卷 / 03期
关键词：
Non-alcoholic fatty liver disease; Polymorphism; Single nucleotide; Genes;
D O I：
10.3350/cmh.2021.0133
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：446 / 447
页数：2
相关论文
共 50 条
  • [41] Egg consumption and risk of non-alcoholic fatty liver disease
    Zeinab Mokhtari
    Hossein Poustchi
    Tannaz Eslamparast
    Azita Hekmatdoost
    World Journal of Hepatology, 2017, (10) : 503 - 509
  • [42] Cardiovascular risk factors in non-alcoholic fatty liver disease
    Hagstrom, Hannes
    Nasr, Patrik
    Ekstedt, Mattias
    Hammar, Ulf
    Stal, Per
    Askling, Johan
    Hultcrantz, Rolf
    Kechagias, Stergios
    LIVER INTERNATIONAL, 2019, 39 (01) : 197 - 204
  • [43] Dietary patterns and risk of non-alcoholic fatty liver disease
    Ammar Salehi-sahlabadi
    Samaneh Sadat
    Sara Beigrezaei
    Makan Pourmasomi
    Awat Feizi
    Reza Ghiasvand
    Amir Hadi
    Cain C. T. Clark
    Maryam Miraghajani
    BMC Gastroenterology, 21
  • [44] Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
    Targher, Giovanni
    Arcaro, Guido
    ATHEROSCLEROSIS, 2007, 191 (02) : 235 - 240
  • [45] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [46] Performance of fibrosis prediction scores in paediatric non-alcoholic fatty liver disease
    Jackson, Jasmine A.
    Konomi, Juna V.
    Mendoza, Michael V.
    Krasinskas, Alyssa
    Jin, Ran
    Caltharp, Shelley
    Mouzaki, Marialena
    Vos, Miriam B.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2018, 54 (02) : 172 - 176
  • [47] Reply to: "Polygenic risk score: A promising predictor for hepatocellular carcinoma in the population with non-alcoholic fatty liver disease"
    Jamialahmadi, Oveis
    Bianco, Cristiana
    Pelusi, Serena
    Romeo, Stefano
    Valenti, Luca
    JOURNAL OF HEPATOLOGY, 2021, 74 (06) : 1494 - 1496
  • [48] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [49] Comparing the performance of Fibrosis-4 and Non-Alcoholic Fatty Liver Disease Fibrosis Score with transient elastography scores of people with non-alcoholic fatty liver disease
    Cox, Ben
    Trasolini, Roberto
    Gaits, Ciaran
    Yoshida, Eric M.
    Marquez, Vladimir
    CANADIAN LIVER JOURNAL, 2021, 4 (03): : 275 - 282
  • [50] UNDERSTANDING RISK FOR NON-ALCOHOLIC STEATOHEPATITIS AND NON-ALCOHOLIC FATTY LIVER DISEASE IN MEDICARE AND MEDICAID CLAIMS
    Nelson, Katherine
    Gellar, Jonathan
    Anderson, Ryan Taylor
    Campbell, Patrick
    Chen, Arnold
    HEPATOLOGY, 2023, 78 : S2146 - S2147
12345